ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology

Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria

(2018) Harvey L. Levy et al.   MOLECULAR GENETICS AND METABOLISM

Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion

(2018) Chen Guo et al.   Artificial Cells Nanomedicine and Biotechnology

Neoepitopes as cancer immunotherapy targets: key challenges and opportunities

(2017) Cory A Brennick et al.   Immunotherapy

Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions

(2017) Thomas Ming Swi Chang   Artificial Cells Nanomedicine and Biotechnology

Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer

(2016) Charles J. Bowerman et al.   NANO LETTERS

Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients

(2016) Mervyn Mer et al.   TRANSFUSION

Non-ionic macroporous polystyrene adsorbents for removal of serum toxins in liver failure by hemoperfusion

(2016) Jian Chen et al.   Artificial Cells Nanomedicine and Biotechnology

Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation

(2015) Wei Song et al.   Scientific Reports

Red blood cell replacement, or nanobiotherapeutics with enhanced red blood cell functions?

(2015) Thomas Ming Swi Chang   Artificial Cells Nanomedicine and Biotechnology

Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C

(2015) Y. Z. Bian et al.   Artificial Cells Nanomedicine and Biotechnology

Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin–superoxide dismutase–catalase–carbonic anhydrase

(2015) C. Guo et al.   Artificial Cells Nanomedicine and Biotechnology

Polymerized human placenta hemoglobin improves resuscitative efficacy of hydroxyethyl starch in a rat model of hemorrhagic shock

(2015) Yaojin Li et al.   Artificial Cells Nanomedicine and Biotechnology

A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume

(2014) Yuzhu Bian et al.   Artificial Cells Nanomedicine and Biotechnology

Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation

(2013) Anne Mari A. Rokstad et al.   ADVANCED DRUG DELIVERY REVIEWS

Argocytes Containing Enzyme Nanoparticles Reduce Toxic Concentrations of Arginine in the Blood

(2012) Yu. G. Kaminsky et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria

(2011) Christineh N. Sarkissian et al.   MOLECULAR GENETICS AND METABOLISM

Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock

(2009) Dinna N. Cruz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Human Polymerized Hemoglobin for the Treatment of Hemorrhagic Shock when Blood Is Unavailable: The USA Multicenter Trial

(2008) Ernest E. Moore et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS